GCG and fatty liver disease: Recently, a novel TGR5 agonist RDX8940, has been reported to improve hepatic steatosis in western diet-fed mice and enhance the secretion of gastrointestinal hormones such as GLP-1, GLP-2, and peptide YY (Finn et al., 2019).